These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34826640)

  • 1. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers.
    Haddad M; Voisin J; Reynes C; Blanc-Jouvan F; Gressin R; Mansard C; Park S; Marlu R
    Thromb Res; 2022 Jan; 209():1-4. PubMed ID: 34826640
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of undetermined significance.
    Puronen CE; Josephson NC; Broudy VC
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):430-2. PubMed ID: 23249617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.
    Green A; Shen YP; Nelson AT; Sarode R; Ibrahim IF; Cao J; Afraz S; Yates SG
    Ann Hematol; 2022 Dec; 101(12):2627-2631. PubMed ID: 36194257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acquired von Willebrand disease and lymphoproliferative syndromes].
    Hunault-Berger M; Rachieru P; Ternisien C; Jardel H; Zandecki M; Boasson M; Ifrah N
    Presse Med; 2001 Feb; 30(5):209-12. PubMed ID: 12385052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib.
    Saldanha A; Veiga ME; Okazaki E; Rothschild C; Martinez G; Rocha V; Orsi FA; Villaca P
    J Thromb Thrombolysis; 2023 May; 55(4):770-774. PubMed ID: 37000318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome associated with monoclonal gammopathy: a single-center study of 36 patients.
    Voisin S; Hamidou M; Lefrançois A; Sigaud M; Mahé B; Trossaërt M
    Medicine (Baltimore); 2011 Nov; 90(6):404-411. PubMed ID: 22033454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
    Mathew Thomas V; Gilreath JA; Newton S; Smock KJ; Lim MY
    Haemophilia; 2021 Jul; 27(4):e563-e566. PubMed ID: 33909921
    [No Abstract]   [Full Text] [Related]  

  • 8. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
    Lavin M; Brophy TM; Rawley O; O'Sullivan JM; Hayden PJ; Browne PV; Ryan K; O'Connell N; O'Donnell JS
    J Thromb Haemost; 2016 Jun; 14(6):1200-5. PubMed ID: 26991062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired von Willebrand syndrome in three patients and literature review].
    Ouyang HY; Yu ZJ; Yin J; Zhao XJ; Wang ZY; Zhang W; Ma ZN; Su J; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):692-5. PubMed ID: 27587252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
    Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
    Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.
    Jeryczynski G; Agis H; Eichinger-Hasenauer S; Krauth MT
    Wien Klin Wochenschr; 2022 Jun; 134(11-12):478-482. PubMed ID: 35305139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand syndrome and lymphoid neoplasms: A review of malignancy management, and propositions of practical recommendations.
    Nicol C; Pan-Petesch B; Ianotto JC
    Haemophilia; 2022 Nov; 28(6):938-949. PubMed ID: 36006003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG kappa monoclonal gammopathy of undetermined significance presenting as acquired type III Von Willebrand syndrome.
    Howard CR; Lin TL; Cunningham MT; Lipe BC
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):631-3. PubMed ID: 24686099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance.
    Ojeda-Uribe M; Caron C; Itzhar-Baikian N; Debliquis A
    Am J Hematol; 2010 May; 85(5):396. PubMed ID: 20425807
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acquired von Willebrand syndrome: a case series of nine patients and literature review].
    Boissier E; Darnige L; Dougados J; Arlet JB; Dupeux S; Georgin-Lavialle S; Caron C; Tapon-Bretaudière J; Pouchot J; Ranque B
    Rev Med Interne; 2014 Mar; 35(3):154-9. PubMed ID: 23746599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of chronic inflammatory demyelinating polyradiculoneuropathy concomitant with acquired von Willebrand syndrome].
    Ueda M; Kawamura N; Tateishi T; Shigeto H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2011 May; 51(5):334-7. PubMed ID: 21706830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.
    Federici AB; Stabile F; Castaman G; Canciani MT; Mannucci PM
    Blood; 1998 Oct; 92(8):2707-11. PubMed ID: 9763553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
    Varettoni M; Zibellini S; Boveri E; Klersy C; Candido C; Rattotti S; Ferretti VV; Defrancesco I; Mangiacavalli S; Nizzoli ME; Flospergher E; Zerbi C; Bergamini F; Benvenuti P; Brociner M; Merati G; Paulli M; Arcaini L
    Br J Haematol; 2019 Nov; 187(4):441-446. PubMed ID: 31276195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and immediate treatment of acquired von Willebrand syndrome revealed by recurrent cerebral hemorrhage.
    Pineau-Vincent F; Legout A; Besancon-Bergelin A; Alani M; Laribi K; Lemaire P
    Transfus Clin Biol; 2019 Nov; 26(4):356-358. PubMed ID: 31262628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.